Bgm (BGM) Common Equity (2019 - 2025)
Bgm (BGM) posted quarterly Common Equity of $391.9 million for Q3 2025, up 788.79% year-over-year from $44.1 million in Q3 2024, and up 113.58% quarter-over-quarter from $183.5 million in Q1 2025.
Bgm (BGM) Common Equity (2019 - 2025) Analysis & Trends
Bgm (BGM) has reported Common Equity for 7 consecutive years, with $391.9 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Common Equity rose 788.79% year-over-year to $391.9 million; the TTM figure through Sep 2025 stood at $391.9 million (up 788.79% YoY), while the FY2025 annual figure was $391.9 million, up 788.79% from the prior year.
- Common Equity improved to $391.9 million in Q3 2025 per BGM's latest filing, from $183.5 million in the prior quarter.
- Across five years, Common Equity topped out at $391.9 million in Q3 2025 and bottomed at $44.1 million in Q3 2024.
- Historically, Common Equity has averaged $103.6 million across 5 years, with a median of $55.0 million in 2022.
- Annual changes were most pronounced in 2023 — Common Equity fell 19.31% — and 2025, when it surged 788.79%.
- Bgm's Common Equity stood at $56.7 million in 2021, then decreased by 3.01% to $55.0 million in 2022, then dropped by 19.31% to $44.4 million in 2023, then declined by 0.58% to $44.1 million in 2024, then soared by 788.79% to $391.9 million in 2025.
- Business Quant data shows BGM's Common Equity at $391.9 million in Q3 2025, $183.5 million in Q1 2025, and $44.1 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 4.05 Bn |
| 10 | Bgm | 30.61 Mn | 20.79 Mn | - | 391.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 391.90 Mn |
| Mar 31, 2025 | 183.49 Mn |
| Sep 30, 2024 | 44.09 Mn |
| Mar 31, 2024 | 44.92 Mn |
| Sep 30, 2023 | 44.35 Mn |
| Mar 31, 2023 | 54.74 Mn |
| Sep 30, 2022 | 54.96 Mn |
| Mar 31, 2022 | 57.51 Mn |
| Sep 30, 2021 | 56.67 Mn |
| Sep 30, 2020 | 28.84 Mn |
| Sep 30, 2019 | 22.64 Mn |